Cytocom
Experienced Chief Executive Officer with a demonstrated history of working in the financial services industry. Skilled in Management, Financial Modeling, Portfolio Management, Due Diligence, and Investments. Strong business development professional with a Master of Business Administration – MBA focused in Accounting and Finance from The Wharton School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Cytocom
Cytocom, Inc. is a clinical-stage biopharmaceutical company developing novel second-generation immune therapies to deliver immune homeostasis based on proprietary platforms. The company has four phases 3 ready programs in Crohn’s Disease, Fibromyalgia, MS, and Pancreatic Cancer.